Aseptic Technologies

Executive Summary

Aseptic Technologies, a Belgian medical device and drug delivery company, is a key enabler for the global biotech industry, particularly in the rapidly growing cell and gene therapy (CGT) sector. The company specializes in ready-to-use aseptic devices, filling lines, and container closure integrity systems, all critical for sterile manufacturing of advanced therapies. As a member of the SKAN Group, it leverages deep expertise in injection molding and aseptic operations to provide state-of-the-art solutions that reduce contamination risks and improve production efficiency. With increasing demand for CGT products and a trend toward outsourcing complex aseptic processes, Aseptic Technologies is well-positioned to capture market share. The company's focus on innovation and partnerships with biotech firms supports its growth trajectory, though it operates in a competitive landscape with established players.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation Ready-to-Use Vial System70% success
• Q4 2026Strategic Partnership with a Major Cell Therapy Developer50% success
• Q1 2027Expansion of Aseptic Filling Capacity in Europe65% success